Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness. It also provides MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports. In addition, the company offers vitamin D assessment services and BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service. The company was formerly known as Zetta Capital Corp. and changed its name to Pangenomic Health Inc. in December 2021. The company was incorporated in 2015 and is based in Vancouver, Canada.
Frequently asked questions
What sector does Pangenomic Health Inc. (NARA) operate in?
Pangenomic Health Inc. belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Pangenomic Health Inc. (NARA) current stock price?
As of the latest data, Pangenomic Health Inc. stock price is CA$0.35, with a previous close of CA$0.40. Pangenomic Health Inc. lost -CA$0.05 in the last trading session, representing a -12.5% loss.
What is Pangenomic Health Inc. (NARA) current market capitalization?
Pangenomic Health Inc. market cap is approximately 9.00 million.
What is Pangenomic Health Inc. (NARA) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.17.
Does Pangenomic Health Inc. (NARA) pay dividends?
No. Pangenomic Health Inc. does not pay a dividend.
What is Pangenomic Health Inc. (NARA) beta (volatility) score?
Pangenomic Health Inc. has a beta of -0.804, indicating lower volatility than the overall market.
